Quality of Life in Early-Stage Cervical Cancer Patients Undergoing Radical Hysterectomy via Minimally Invasive or Open Surgery: The LACC Trial

INCIDENCE OF ADVERSE EVENTS COMPARING ABDOMINAL VS. MINIMALLY INVASIVE RADICAL HYSTERECTOMY IN PATIENTS WITH EARLY-STAGE CERVICAL CANCER: LACC TRIAL

INCIDENCE OF ADVERSE EVENTS COMPARING ABDOMINAL VS. MINIMALLY INVASIVE RADICAL HYSTERECTOMY IN PATIENTS WITH EARLY-STAGE CERVICAL CANCER: LACC TRIAL Andreas Obermair, Rebecca Asher, Michael Frumovitz,

Disclosure. No Conflicts of Interest

Phase III Randomized Trial of Laparoscopic or Robotic Radical Hysterectomy vs. Abdominal Radical Hysterectomy in Patients with Early-Stage Cervical Cancer: LACC Trial Pedro T. Ramirez, Michael Frumovitz,

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial

Gynecologic Cancer InterGroup Cervix Cancer Research Network The SHAPE Trial Comparing radical hysterectomy and pelvic node dissection against simple hysterectomy and pelvic node dissection in patients

Role of Surgery in Cervical Cancer & Research Questions

Role of Surgery in Cervical Cancer & Research Questions Arb-aroon Lertkhachonsuk, M.D., Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Role of surgery in cervical cancer

ECC or Margins Positive?

CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,

Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante

Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data David Cibula Gynecologic Oncology Centre General University Hospital

JK Coller, S Korver, IA Ball, RJ Gibson, J Tuke, RM Logan, AM Richards, KR Mead, CS Karapetis, DM Keefe and JM Bowen

JK Coller, S Korver, IA Ball, RJ Gibson, J Tuke, RM Logan, AM Richards, KR Mead, CS Karapetis, DM Keefe and JM Bowen Incidence of other toxicities in patients with severe gastrointestinal toxicity and

FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS

FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS Frieda Matthys, MD, PhD, University Hospital Brussels and Vrije Universiteit Brussels (VUB), Belgium PeterJoostens, MD, Psychiatric Centre

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Original Article Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer Pedro T. Ramirez, M.D., Michael Frumovitz, M.D., Rene Pareja, M.D., Aldo Lopez, M.D., Marcelo Vieira, M.D., Reitan Ribeiro,

SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA

Lead Grou p Log SLN Mapping in Cervical Cancer Nadeem R. Abu-Rustum, M.D. Memorial Sloan Kettering Cancer Center New York, USA Conflict of Interest Disclosure Nadeem R. Abu-Rustum, M.D. I have no financial

Lung Cancer in Older Adults.. Appropriate treatment?

Lung Cancer in Older Adults.. Appropriate treatment? Faculty Disclosure X No, nothing to disclose Yes, please specify: Dr Christopher Steer Border Medical Oncology Albury-Wodonga Inaugural Chair Geriatric

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review

Faculty Disclosure. No, nothing to disclose Yes, please specify: Medtronic Johnson & Johnson. Ownership/ Equity Position.

Diabeloop Closed-Loop does better than Sensor-augmented Pump on blood glucose control during 3 days with gastronomic dinners: a randomized crossover trial in Patients with Type 1 Diabetes. Hélène Hanaire

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications Andres A. Roma, MD Cleveland Clinic No Disclosures In the past 12 months, I have not had

Developing Supportive Care in Serbia

Developing Supportive Care in Serbia Prof Snežana Bošnjak Institute for Oncology and Radiology of Serbia National Cancer Center Dept. Supportive Oncology & Palliative Care ESO & ESMO Faculty member Faculty

Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer

대한부인종양콜포스코피학회제 24 차학술대회 Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer Seoul National University Bundang Hospital Eun Jung Soh, M.D. Cervical cancer

VTE Risk Assessment. Challenges of Hemostasis in Cancer Patients. Cihan Ay, MD Associate Professor

Challenges of Hemostasis in Cancer Patients VTE Risk Assessment Cihan Ay, MD Associate Professor Clinical Division of Haematology and Haemostaseology Department of Medicine I, Comprehensive Cancer Center

Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2

Preoperative nomogram for individualized prediction of parametrial invasion in patients with FIGO stage IB cervical cancer treated with radical hysterectomy Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous

Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior

Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.

Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS)

Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS) Shyamala C. Navada, MD 1, Guillermo Garcia-Manero, MD 2, Katherine Hearn, RN 2, Rosalie Odchimar-Reissig,

International prospective validation trial of sentinel node biopsy in cervical cancer

Cervix cancer committee International prospective validation trial of sentinel node biopsy in cervical cancer N Abu-Rustum, F Lécuru, P Mathevet, M Plante. F Bonnetain (Statistics) G Chatellier (Clinical

TGR5 activation induces intestinal growth and improves intestinal mucositis in mice. Hannelouise Kissow

TGR5 activation induces intestinal growth and improves intestinal mucositis in mice Hannelouise Kissow Department of Biomedical Sciences Faculty of Health and Medical Sciences Faculty Disclosure x No,

Analysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix

DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals

6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy

Early drug development and emerging new treatments Unmasking Side Effects from First-in-Man Antineoplastic Medicine

Early drug development and emerging new treatments Unmasking Side Effects from First-in-Man Antineoplastic Medicine Ulrik Lassen, Professor, MD, PH.D. Phase 1 Unit, www.rigshospitalet.dk/phase1 Department

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

GCIG Rare Tumour Brainstorming Day

GCIG Rare Tumour Brainstorming Day Relatively (Not So) Rare Tumours Adenocarcinoma of Cervix Keiichi Fujiwara, Ros Glasspool Benedicte Votan, Jim Paul Aim of the Day To develop at least one clinical trial

Supplementary Appendix

Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after

Oncotype DX testing in node-positive disease

Should gene array assays be routinely used in node positive disease? Yes Christy A. Russell, MD University of Southern California Oncotype DX testing in node-positive disease 1 Validity of the Oncotype

Patients Expectations of Foot and Ankle Surgery: Variations by Diagnosis

Patients Expectations of Foot and Ankle Surgery: Variations by Diagnosis Elizabeth A Cody, MD; Jayme C. B. Koltsov, PhD; Anca Marinescu; Carol A. Mancuso, MD; Scott J Ellis, MD; HSS Orthopaedic Foot and

Role of Robotic Surgery in Endometrial Cancer: New Expensive Gadget or the Future?

Role of Robotic Surgery in Endometrial Cancer: New Expensive Gadget or the Future? Kathleen Yang, MD, FACOG Northwest Gynecologic Oncology Willamette Valley Cancer Institute Disclosure I have nothing to

Radiotherapy & Cervical Cancer Dr Mary McCormack Consultant Clinical Oncologist University College Hospital, London,UK

Lead Group Log Radiotherapy & Cervical Cancer Dr Mary McCormack Consultant Clinical Oncologist University College Hospital, London,UK Cervical Cancer treatment Treatment planning should be made on a multidisciplinary

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department

Rochester Minnesota Mayo Clinic

Are There Still Indications for Lymphadenectomy in Endometrial Cancer? A Mariani Mayo Clinic Rochester - MN USA Rochester Minnesota Mayo Clinic 1 Endometrial Cancer Lymphadenectomy Yes or No? Endometrial

HISTORY SURGERY FOR TUMORS WITH INVASION OF THE APEX 15/11/2018

30 EACTS Annual Meeting Barcelona, Spain 1-5 October 2016 SURGERY FOR TUMORS WITH INVASION OF THE APEX lung cancer of the apex of the chest involving any structure of the apical chest wall irrespective

Early radical cystectomy in NMIBC Marko Babjuk

Early radical cystectomy in NMIBC Marko Babjuk Dept. of Urology, 2nd Faculty of Medicine, Hospital Motol, Praha, Czech Republic We Are The European Association of Urology We Are Urologists, residents,

Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage

Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage Prof. Charbell Miguel Haddad Kury, MD Pediatrician Infectious

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical

EXPLICIT PROGNOSTIC DISCLOSURE TO ASIAN WOMEN WITH BREAST CANCER: A RANDOMIZED SCRIPTED VIDEO- VIGNETTE STUDY (J-SUPPORT 1601)

EXPLICIT PROGNOSTIC DISCLOSURE TO ASIAN WOMEN WITH BREAST CANCER: A RANDOMIZED SCRIPTED VIDEO- VIGNETTE STUDY (J-SUPPORT 1601) Masanori Mori, MD, Maiko Fujimori, PhD (Co-primary authors), Liesbeth M. van

Faculty Disclosure. No, nothing to disclose Yes, please specify: Novo-Nordisk. Roche. Abbott. Funded Research. Ownership/ Equity Position

Diabeloop Closed-Loop does better than sensor-augmented-pump on blood glucose during 3 days with intensive physical eercises: a randomized crossover trial. Sylvia Franc 1, MD, Sophie Borot, MD, PhD, Pierre-Yves

Cervixcancer. Vad är aktuellt? Jan Persson. Lund. Docent överläkare Dep of OB&G Skane univ hosp Lund Sweden

Cervixcancer Copyright Jan Persson Lund Vad är aktuellt? Jan Persson Docent överläkare Dep of OB&G Skane univ hosp Lund Sweden Controversies Preop selection related stage ( stage 1b1>= 2 cm) Neoadjuvant

Cancer patients experiences with an early palliative care conversation: A qualitative study of an intervention based on the SENS-structure

UCI / University Center for Palliative Care Cancer patients experiences with an early palliative care conversation: A qualitative study of an intervention based on the SENS-structure MC Fliedner 1,3, S

Symptom Severity, Quality of Life and Work Productivity of US Psoriasis Patients During Periods of Flare and Remission

Symptom Severity, Quality of Life and Work Productivity of US Psoriasis Patients During Periods of Flare and Remission 93 Korman, NJ 1, Zhao, Y 2, Roberts, J 3 Pike, J 3, Lu, J 2, Tran, MH 2 (Please see

17 th ESO-ESMO Masterclass in clinical Oncology

17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated

Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Andrew J. Stephenson, MD, FRCSC, FACS Director, Urologic Oncology Associate Professor of Surgery Glickman Urological and Kidney

What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital

Thai Journal of Obstetrics and Gynaecology April 2008, Vol. 16, pp. 79-8561-167 SPECIAL ARTICLE What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital Jatupol

Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy

SCIENTIFIC PAPER Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy Noah Rindos, MD, Christine L. Curry, MD, PhD, Rami Tabbarah, MD, Valena Wright, MD ABSTRACT Background and Objectives:

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator

Does RT favor RP in long term Quality of Life? Juanita Crook MD FRCPC Professor of Radiation Oncology University of British Columbia

Does RT favor RP in long term Quality of Life? Juanita Crook MD FRCPC Professor of Radiation Oncology University of British Columbia Disclosures Advisory Board/honoraria: Varian Advisory Board: Breast

Risk Factors for Failing Cervical Cancer. Time of Simple Hysterectomy

Risk Factors for Failing Cervical Cancer Screening in Incidental Cervical Carcinoma at Time of Simple Hysterectomy Tara Castellano, MD Gynecologic Oncology Fellow Oklahoma Health Sciences Center, Stephenson

From Research to Practice: What s New in Gynecologic Cancers?

From Research to Practice: What s New in Gynecologic Cancers? David Warshal, M.D. Head, Division of Gynecologic Oncology MD Anderson Cooper Cancer Institute Associate Professor of Obstetrics and Gynecology

Locally advanced disease & challenges in management

Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

Laparoscopic Management of Early Stage Endometrial Cancer. B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G.

Laparoscopic Management of Early Stage Endometrial Cancer B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G. Mage Early Stage of Endometrial Cancer most of cases diagnosed (clinical

Disclosures. The Value Agenda in Spine Care Steven D. Glassman, M.D. 10/14/16. AllinaHealthSystems 1. Introduction. Introduction.

The Value Agenda in Spine Care Steven D. Glassman, M.D. Professor of Orthopedic Surgery University of Louisville Norton Leatherman Spine Center Past-President, Scoliosis Research Society Medtronic Disclosures

National Cervical Screening Programme. Annual Report 2014

National Cervical Screening Programme Annual Report 2014 Report prepared February 2017 Revised May 2017 Finalised June 2017 Report prepared by Megan Smith, Leanne Rumlee and Karen Canfell. Cancer Research

Approaches to Surgical Treatment of Gastric Cancer. Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service

Approaches to Surgical Treatment of Gastric Cancer Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service Disclosures I do not have anything to disclose Outline Background Diagnosis Histology Staging Surgery

Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer

Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Nicoletta Colombo, MD University of Milan-Bicocca European Institute of Oncology Milan, Italy NACT in Cervical Cancer NACT Stage -IB2 -IIA>4cm

GP Education Series Women s cancers. GP Education Day 11 July 2016

GP Education Series Women s cancers GP Education Day July 26 The Royal Marsden Endometrial cancer- A side effect of bigger health problems Mr Thomas Ind Consultant Gynaecology oncology surgeon The Royal

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.

HPV Primary Screening in the United States

IFCPC 15th World Congress May 2014, London, UK. HPV Primary Screening in the United States E.J. Mayeaux, Jr., M.D. Professor and Chairman Department of Family and Preventive Medicine Professor of Obstetrics

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department

Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer

J Gynecol Oncol. 2018 May;29(3):e41 pissn 2005-0380 eissn 2005-0399 Original Article Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer Antonino Ditto, Giorgio Bogani, Umberto

Background Information

Background Information Age plays an important role in patients selection for spinal surgeries as it is associated with increased morbidity and mortality Consequences of suffering postoperative complications

Treatment of oligometastatic NSCLC

Treatment of oligometastatic NSCLC Jarosław Kużdżał Department of Thoracic Surgery Jagiellonian University Collegium Medicum, John Paul II Hospital, Cracow New idea? 14 NSCLC patients with solitary extrathoracic

Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic

Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic Oncology Scott Department of Urology Baylor College of

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial

receive adjuvant chemotherapy

Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1

What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? Ph Nafteux, MD Copenhagen, Nov 3rd 2011 Department of Thoracic Surgery, University Hospitals Leuven, Belgium W. Coosemans, H. Decaluwé, Ph.

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most

Cervical Cancer Guidelines L and SC Network July Introduction:

Cervical Cancer Guidelines L and SC Network July 2018 Introduction: There was a total number of 442 cases of cervix cancer diagnosed in Lancashire and South Cumbria Cancer Network in the period 2005 2009

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND

Types of bladder cancer

There are three main types of bladder cancer: Urothelial bladder cancer Squamous cell cancer Adenocarcinoma of the bladder There is more information about how we treat the different types of bladder cancer

Comparison of modified Cherney incision and vertical midline incision for management of early stage cervical cancer

J Gynecol Oncol Vol. 9, No. 4:246-250, December 2008 DOI:0.3802/jgo.2008.9.4.246 Original Article Comparison of modified incision and vertical incision for management of early stage cervical cancer San

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer

Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical

Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer

Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer Jason D. Wright, MD, Yongemei Huang, MD/PhD, William M. Burke, MD, et al. Journal Club March 16, 2016 Blaine Campbell-PGY2 Objective

pan-canadian Oncology Drug Review Final Clinical Guidance Report Bevacizumab (Avastin) for Cervical Cancer March 23, 2015

pan-canadian Oncology Drug Review Final Clinical Guidance Report Bevacizumab (Avastin) for Cervical Cancer March 23, 2015 DISCLAIMER Not a Substitute for Professional Advice This report is primarily intended

Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience

Original Article on Cervical Cancer Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience Claudia Arispe, Ana Isabel Pomares, Javier De Santiago,

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines

Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology

Jane T Osterhaus 1* and Oana Purcaru 2

Osterhaus and Purcaru Arthritis Research & Therapy 2014, 16:R164 RESEARCH ARTICLE Open Access Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing

imanagecancer Results of a European R&D Project on Empowering Pa8ents and Strengthening Self-Management in Cancer Diseases

imanagecancer Results of a European R&D Project on Empowering Pa8ents and Strengthening Self-Management in Cancer Diseases Stephan Kiefer, Fraunhofer Ins8tute Biomedical Engineering, St. Ingbert, Germany

Chapter 8 Adenocarcinoma

Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

Patient Selection for Surgery in RCC with Thrombus E. Jason Abel, M.D. RCC with venous invasion Venous invasion occurs in ~10% of RCC Surgery more complex Increased risk for morbidity Thrombus may be confined

Non-small Cell Lung Cancer: Multidisciplinary Role: Role of Medical Oncologist

Non-small Cell Lung Cancer: Multidisciplinary Role: Role of Medical Oncologist Vichien Srimuninnimit, MD. Medical Oncology Division Faculty of Medicine, Siriraj Hospital Outline Resectable NSCLC stage

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป Brachytherapy การร กษาด วยร งส ระยะใกล Insertion การสอดใส แร Implantation การฝ งแร Surface application การวางแร physical benefit of brachytherapy - very high dose of radiation

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year

National Cancer Institute

Patient- reported outcome surveillance in older cancer survivors: Using the SEER-MHOS linked data resource Erin E. Kent, PhD Epidemiologist & Program Director Outcomes Research Branch Applied Research

BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE

BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE Ελένη Κορομπόκη, MD, PhD, FESO Α Νευρολογική Κλινική, ΕΚΠΑ, Αιγινήτειο Νοσοκομείο Κλινική Ερευνήτρια, Department of Stroke Medicine, Imperial College London,

Surgical Progress in the Management in Gynecologic Cancers

Surgical Progress in the Management in Gynecologic Cancers Stephen J. Lee, MD Assistant Professor stelee@coh.org September 19, 2018 Nothing to disclose DISCLOSURE Defining Minimally Invasive Surgery: Hysterectomy

status should be eligible for treatment with atezolizumab. perc acknowledged the small number of patients with an EGFR or ALK mutation positive disease recruited on the trials but agreed that the overall

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Approaches

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Approaches Ellen Lavoie Smith PhD, APRN, AOCN, FAAN Associate Professor PhD Program Director University of Michigan School of Nursing Faculty

1/22/2016. This speaker has no conflicts of interest to disclose relative to the contents of this presentation. AAGL Spokesperson for Morcellation

The Morcellation Controversy Jubilee Brown, M.D. Professor The University of Texas M.D. Anderson Cancer Center Department of Gynecologic Oncology 30th Sanford H. Cole Symposium January 29, 2016 This speaker